S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.50
+1.82
+10.91%
ARDT · Ardent Health, Inc.
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
Ardent Health Inc (ARDT)
NEW YORK STOCK EXCHANGE, INC.
Health Care
$12.07
-0.05
(-0.41%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$12.07
$11.98
$12.14
52-WEEK RANGE
$12.07
$7.71
$15.48
What's happening
- ARDT is down 0.41% today, trading at $12.07. — Live quote
- Volume today (29,397) is well below its 3-month average of 486,330. (Finnhub fundamentals)
- Reports earnings on 2026-11-04, 13 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $0.12 actual vs. $0.18 estimated (-35.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 7
Hold 6
Sell 1
Strong sell 0
Aggregate ratings for 2026-10-01 (19 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ARDT
+36.58%
vs S&P 500
+23.21%
1-YEAR RETURN
ARDT
-19.44%
vs S&P 500
-34.60%
6-MONTH RETURN
ARDT
+21.70%
3-MONTH RETURN
ARDT
+16.30%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.12
Est. $0.18
MISS -35.1%
2026-04-26 (Q1 2026)
$0.28
Est. $0.19
BEAT +48.6%
2026-01-26 (Q4 2025)
$0.32
Est. $0.35
MISS -8.2%
2025-10-26 (Q3 2025)
$0.52
Est. $0.42
BEAT +24.8%
Valuation Measures & Ratios
Enterprise Value4$2.08B
Forward P/E512.63
PEG Ratio6—
Price / Sales (TTM1)0.27
Price / Book71.04
EV4 / Revenue0.32
EV4 / EBITDA5.01
Profit Margin1.22%
Operating Margin3.91%
Return on Equity (ROE8)6.00%
Return on Assets (ROA9)1.49%
Avg Volume (3M)486,330
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.39B | $1.22B | $1.22B | $1.28B | $1.31B |
| P/E | 13.09 | 9.32 | 10.42 | 6.96 | 9.54 |
| Price/Sales | 0.22 | 0.19 | 0.20 | 0.21 | 0.22 |
| Price/Book | 1.03 | 0.91 | 0.99 | 1.02 | 1.12 |
| EV/Revenue | 0.27 | 0.27 | 0.28 | 0.30 | 0.33 |
| ROE | 7.87% | 9.78% | 9.46% | 14.62% | 11.70% |
| ROA | 2.01% | 2.49% | 2.27% | 3.65% | 2.80% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short4,632,524
Change from Prior Settlement+1.22%
% of Float—
Days to Cover (Short Ratio)10.71
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-09-29; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -1.4% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 1.2%. Finnhub fundamentals ↗
- Trailing 52-week price return is -19.4%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ARDT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.62B | $1.60B | $1.58B | $1.65B | $1.50B | $1.45B | $1.47B | $1.44B |
| Net income | $16.9M | $39.9M | -$23.5M | $73.0M | $41.4M | $26.3M | $42.8M | $27.0M |
| EPS (diluted) | $0.12 | $0.28 | $-0.17 | $0.52 | $0.29 | $0.19 | $0.34 | $0.21 |
| EPS (basic) | $0.12 | $0.28 | $-0.17 | $0.52 | $0.30 | $0.19 | $0.34 | $0.21 |
| Net margin | $1 | $2 | -$1 | $4 | $3 | $2 | $3 | $2 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $5.28B | $5.25B | $5.29B | $5.15B | $5.03B | $4.91B | $4.96B | $4.80B |
| Total liabilities | $3.54B | $3.52B | $3.61B | $3.52B | $3.38B | $3.35B | $3.43B | $3.41B |
| Stockholders' equity | $1.35B | $1.34B | $1.29B | $1.24B | $1.25B | $1.18B | $1.13B | $1.01B |
| Total current assets | $2.05B | $2.02B | $2.06B | $1.96B | $1.88B | $1.76B | $1.83B | $1.69B |
| Total current liabilities | $976.3M | $951.5M | $1.05B | $943.2M | $880.9M | $830.1M | $945.4M | $887.3M |
| Cash & equivalents | $724.5M | $609.7M | $709.6M | $609.4M | $540.6M | $495.0M | $556.8M | $563.1M |
| Accounts receivable | $696.0M | $686.0M | $686.1M | $729.4M | $758.6M | $776.5M | $743.0M | $705.7M |
| Inventory | $116.0M | $119.8M | $118.6M | $121.6M | $118.4M | $120.4M | $115.1M | $108.2M |
| Other current assets | $370.5M | $438.1M | $431.9M | $366.1M | $331.6M | $239.0M | $304.1M | $193.6M |
| Property, plant & equipment | — | — | — | $888.0M | $870.4M | $856.5M | $861.9M | $814.9M |
| Goodwill | $879.3M | $879.3M | $879.5M | $877.5M | $877.7M | $876.6M | $852.1M | $852.0M |
| Intangible assets | — | — | $12.4M | — | — | — | — | — |
| Other non-current assets | $123.7M | $116.3M | $111.7M | $111.6M | $111.2M | $116.9M | $143.0M | $137.3M |
| Accounts payable | $429.8M | $419.7M | $457.9M | $381.9M | $364.4M | $371.9M | $401.2M | $368.9M |
| Short-term debt | $28.6M | $37.6M | $23.4M | $19.3M | $19.3M | $17.8M | $9.2M | $12.2M |
| Long-term debt | $1.07B | $1.07B | $1.08B | $1.09B | $1.09B | $1.09B | $1.09B | $1.08B |
| Other non-current liabilities | $81.8M | $66.0M | $76.6M | $62.5M | $31.8M | $31.6M | $34.7M | $53.7M |
| Common stock & paid-in capital | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M |
| Retained earnings | $558.4M | $541.5M | $501.6M | $456.7M | $480.1M | $407.2M | $365.8M | $251.6M |
| Accumulated other comprehensive income (loss) | -$638.0K | -$2.4M | -$3.6M | -$2.6M | -$396.0K | $3.9M | $9.7M | $9.5M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $196.7M | -$60.2M | $223.4M | $154.4M | $117.5M | -$24.8M | $119.6M | $89.7M |
| Investing cash flow | -$39.2M | -$27.9M | -$86.2M | -$58.6M | -$46.2M | -$23.1M | -$105.4M | -$44.5M |
| Financing cash flow | -$42.8M | -$11.8M | -$37.0M | -$26.9M | -$25.7M | -$13.8M | -$20.5M | $183.4M |
| Depreciation & amortization | $41.3M | $43.0M | $41.0M | $39.2M | $39.3M | $36.2M | $37.9M | $36.8M |
| Deferred income taxes | $3.5M | -$429.0K | $28.7M | $17.6M | -$793.0K | -$1.9M | $21.6M | $2.6M |
| Change in accounts receivable | $9.9M | -$32.0K | -$42.6M | -$30.8M | -$16.5M | $30.7M | $37.3M | -$15.3M |
| Change in inventory | -$3.8M | $1.2M | -$3.2M | $3.2M | -$2.1M | $5.2M | $6.9M | $3.1M |
| Other investing activities | $503.0K | -$187.0K | -$271.0K | -$172.0K | $50.0K | $214.0K | $969.0K | $796.0K |
| Dividends paid | — | — | — | — | — | — | $0 | — |
| Share repurchases | $13.0M | — | — | — | $0 | — | — | — |
| Debt issued | — | — | $0 | $0 | $0 | $0 | $0 | $1.8M |
| Debt repaid | $3.3M | $3.6M | $3.5M | $1.6M | $1.5M | $1.4M | $2.0M | $1.5M |
| Other financing activities | $1.7M | -$1.0M | -$3.4M | -$330.0K | -$438.0K | -$1.1M | $5.2M | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Revenue | $6.32B | $5.97B | $5.41B | $5.13B |
| Net income | $135.8M | $210.3M | $53.9M | $188.9M |
| EPS (diluted) | $0.96 | $1.58 | $0.43 | $1.50 |
| EPS (basic) | $0.96 | $1.59 | $0.43 | $1.50 |
| Net margin | $2 | $4 | $1 | $4 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Total assets | $5.29B | $4.96B | $4.73B | — |
| Total liabilities | $3.61B | $3.43B | $3.65B | — |
| Stockholders' equity | $1.29B | $1.13B | $670.9M | — |
| Total current assets | $2.06B | $1.83B | $1.62B | — |
| Total current liabilities | $1.05B | $945.4M | $994.1M | — |
| Cash & equivalents | $709.6M | $556.8M | $437.6M | — |
| Accounts receivable | $686.1M | $743.0M | $775.5M | — |
| Inventory | $118.6M | $115.1M | $105.5M | — |
| Other current assets | $431.9M | $304.1M | $222.3M | — |
| Property, plant & equipment | — | $861.9M | $811.1M | — |
| Goodwill | $879.5M | $852.1M | $844.7M | $844.7M |
| Intangible assets | $12.4M | — | — | — |
| Other non-current assets | $111.7M | $143.0M | $147.1M | — |
| Accounts payable | $457.9M | $401.2M | $474.5M | — |
| Short-term debt | $23.4M | $9.2M | $18.6M | — |
| Long-term debt | $1.08B | $1.09B | $1.17B | — |
| Other non-current liabilities | $76.6M | $34.7M | $76.0M | — |
| Common stock & paid-in capital | $1.4M | $1.4M | $0 | — |
| Retained earnings | $501.6M | $365.8M | $155.5M | — |
| Accumulated other comprehensive income (loss) | -$3.6M | $9.7M | $18.6M | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Operating cash flow | $470.5M | $315.0M | $221.7M | -$38.4M |
| Investing cash flow | -$214.2M | -$220.5M | -$138.0M | $46.6M |
| Financing cash flow | -$103.5M | $24.6M | -$102.3M | -$270.3M |
| Depreciation & amortization | $155.7M | $146.3M | $140.8M | $138.2M |
| Deferred income taxes | $43.6M | $23.3M | $4.8M | $46.1M |
| Change in accounts receivable | -$59.2M | -$40.0M | $181.1M | $17.2M |
| Change in inventory | $3.1M | $9.4M | -$1.7M | -$4.7M |
| Other investing activities | -$179.0K | $1.7M | $575.0K | $8.7M |
| Dividends paid | — | $0 | $0 | $174.8M |
| Debt issued | $0 | $3.6M | $6.6M | $878.0K |
| Debt repaid | $8.0M | $108.4M | $13.6M | $17.3M |
| Other financing activities | -$5.2M | $5.2M | -$7.2M | -$10.3M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ARDT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-11 to 2026-09-25
Recent transactions
- Insiders have net bought 21,260 shares over the last 182 days, across 2 purchases and 0 sales.
- Most recent: LUMSDAINE ALFRED (Chief Financial Officer) — Tax withholding of 3,389 shares on 2026-09-25.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)21,260 sh(2 txns)
Sales (open market)0 sh(0 txns)
Net Shares+21,260
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| LUMSDAINE ALFRED | Chief Financial Officer | Tax withholding | 2026-09-25 | 3,389 |
| Petrovich Stephen C. | EVP, GC and Secretary | Tax withholding | 2026-09-25 | 788 |
| Byers David Raynor | SVP & Chief Accounting Officer | Tax withholding | 2026-09-25 | 524 |
| Caspers Dave | CEO and President | Grant / award | 2026-07-01 | 103,653 |
| DeMichiei Robert | Director | Open market purchase | 2026-06-05 | 11,260 |
| Bulgarelli Peter J. | Director | Grant / award | 2026-04-01 | 14,231 |
| Havdala Ellen | Director | Grant / award | 2026-04-01 | 14,231 |
| Sotir Mark R | Director | Grant / award | 2026-04-01 | 14,231 |
| Sen Rahul | Director | Grant / award | 2026-04-01 | 14,231 |
| Webb Robert Thomas | Director | Grant / award | 2026-04-01 | 14,231 |
| Robinson Edmondo | Director | Grant / award | 2026-04-01 | 14,231 |
| GOODYEAR WILLIAM M | Director | Grant / award | 2026-04-01 | 14,231 |
| Campion Suzanne | Director | Grant / award | 2026-04-01 | 14,231 |
| BYNOE PETER C B | Director | Grant / award | 2026-04-01 | 14,231 |
| Bonick Martin | President and CEO | Tax withholding | 2026-04-01 | 10,952 |
| Chernin Ethan | President of Health Services | Grant / award | 2026-03-11 | 32,408 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-25 | LUMSDAINE ALFRED | Chief Financial Officer | Tax withholding | 3,389 | $10.54 |
| 2026-09-25 | Petrovich Stephen C. | EVP, GC and Secretary | Tax withholding | 788 | $10.54 |
| 2026-09-25 | Byers David Raynor | SVP & Chief Accounting Officer | Tax withholding | 524 | $10.54 |
| 2026-07-01 | Caspers Dave | CEO and President | Grant / award | 103,653 | $0.00 |
| 2026-06-05 | DeMichiei Robert | Director | Open market purchase | 11,260 | $8.73 |
| 2026-06-05 | LUMSDAINE ALFRED | Chief Financial Officer | Open market purchase | 10,000 | $8.81 |
| 2026-04-01 | Bulgarelli Peter J. | Director | Grant / award | 14,231 | $0.00 |
| 2026-04-01 | Havdala Ellen | Director | Grant / award | 14,231 | $0.00 |
| 2026-04-01 | Sotir Mark R | Director | Grant / award | 14,231 | $0.00 |
| 2026-04-01 | Sen Rahul | Director | Grant / award | 14,231 | $0.00 |
| 2026-04-01 | Webb Robert Thomas | Director | Grant / award | 14,231 | $0.00 |
| 2026-04-01 | Robinson Edmondo | Director | Grant / award | 14,231 | $0.00 |
| 2026-04-01 | DeMichiei Robert | Director | Grant / award | 14,231 | $0.00 |
| 2026-04-01 | GOODYEAR WILLIAM M | Director | Grant / award | 14,231 | $0.00 |
| 2026-04-01 | Campion Suzanne | Director | Grant / award | 14,231 | $0.00 |
| 2026-04-01 | BYNOE PETER C B | Director | Grant / award | 14,231 | $0.00 |
| 2026-04-01 | Caspers Dave | Chief Operating Officer | Tax withholding | 2,684 | $8.67 |
| 2026-04-01 | Caspers Dave | Chief Operating Officer | Grant / award | 35,673 | $0.00 |
| 2026-04-01 | Petrovich Stephen C. | EVP, GC and Secretary | Tax withholding | 1,808 | $8.67 |
| 2026-04-01 | Petrovich Stephen C. | EVP, GC and Secretary | Grant / award | 24,904 | $0.00 |
| 2026-04-01 | Byers David Raynor | SVP & Chief Accounting Officer | Tax withholding | 924 | $8.67 |
| 2026-04-01 | Byers David Raynor | SVP & Chief Accounting Officer | Grant / award | 11,538 | $0.00 |
| 2026-04-01 | LUMSDAINE ALFRED | Chief Financial Officer | Tax withholding | 4,381 | $8.67 |
| 2026-04-01 | LUMSDAINE ALFRED | Chief Financial Officer | Grant / award | 53,846 | $0.00 |
| 2026-04-01 | Bonick Martin | President and CEO | Tax withholding | 10,952 | $8.67 |
| 2026-04-01 | Bonick Martin | President and CEO | Grant / award | 134,615 | $0.00 |
| 2026-03-31 | Petrovich Stephen C. | EVP, GC and Secretary | Tax withholding | 1,425 | $8.56 |
| 2026-03-31 | Byers David Raynor | SVP & Chief Accounting Officer | Tax withholding | 819 | $8.56 |
| 2026-03-31 | LUMSDAINE ALFRED | Chief Financial Officer | Tax withholding | 2,510 | $8.56 |
| 2026-03-31 | Bonick Martin | President and CEO | Tax withholding | 8,026 | $8.56 |
| 2026-03-11 | Petrovich Stephen C. | EVP, GC and Secretary | Grant / award | 34,733 | $0.00 |
| 2026-03-11 | LUMSDAINE ALFRED | Chief Financial Officer | Grant / award | 61,081 | $0.00 |
| 2026-03-11 | Chernin Ethan | President of Health Services | Grant / award | 32,408 | $0.00 |
| 2026-03-11 | Bonick Martin | President and CEO | Grant / award | 195,316 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:22 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-29 | 4 | 2026-09-25 | View on SEC.gov → |
| 2026-09-29 | 4 | 2026-09-25 | View on SEC.gov → |
| 2026-09-29 | 4 | 2026-09-25 | View on SEC.gov → |
| 2026-09-04 | 8-K | 2026-09-04 | View on SEC.gov → |
| 2026-08-10 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-04 | 8-K | 2026-08-04 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-06-30 | 8-K | 2026-06-26 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-02 | 8-K | 2026-06-02 | View on SEC.gov → |
| 2026-05-26 | 8-K | 2026-05-20 | View on SEC.gov → |
Recent news
Headlines about ARDT (Ardent Health, Inc.). Links open the publisher — we don’t host full articles.
-
Ardent Health names Gaurav Khanna as chief digital officer By Investing.com
Investing.com India · 2026-10-21 -
Ardent Health Appoints Gaurav Khanna as Chief Digital & Information Officer
Yahoo · 2026-10-21 -
He led tech strategy for a nearly $11 billion business. Now he joins Ardent Health.
Stock Titan · 2026-10-21 -
Wondering Why Ardent Health Fell? What The Bears Saw
Simply Wall Street · 2026-10-20 -
Technical Reactions to ARDT Trends in Macro Strategies
Stock Traders Daily · 2026-10-18 -
Top Ardent Health (ARDT) Competitors 2026
MarketBeat · 2026-10-16 -
Ardent Health Q3FY26 Results: Earnings call set for Nov 5
scanx.trade · 2026-10-15 -
Ardent Health Announces Third Quarter 2026 Results Conference Call and Webcast Date
Yahoo · 2026-10-15
No headlines in this category right now — try “All”.